TITLE

Network encourages close ties to patients

PUB. DATE
May 2007
SOURCE
Clinical Trials Administrator;May2007, Vol. 5 Issue 5, p52
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers information on the Rare Diseases Clinical Research Network. The network is sponsored by the U.S. National Institutes of Health and helps in the recruitment of study participants in clinical trials. It helps in the recruitment of patients by way of encouraging research sites and patient advocacy groups to cooperate.
ACCESSION #
24730855

 

Related Articles

  • NIH Launches Clinical Trials Awareness Site.  // For the Record (Great Valley Publishing Company, Inc.);3/12/2012, Vol. 24 Issue 5, p30 

    The article reviews the web site, NIH Clinical Research Trial and You, located at http://nih.gov/health/clinicaltrials, from the U.S. National Institute of Health (NIH).

  • It's All about Patients. Bergstresser, Paul R. // Journal of Investigative Dermatology;Jan2010, Vol. 130 Issue 1, p1 

    The author reflects on the significance of patients in research studies as well as the impact of their disease in the U.S. He mentions that the patient advocate organizations are guided with the goals and mission of the National Institute of Health (NIH) . He notes that the target of funding and...

  • Patient and public involvement to support liver disease research. Hull, Diana; Barton, Darren; Guo, Kathy; Russell, Christina; Aucott, Bernadette; Wiles, Donna // British Journal of Nursing;9/13/2012, Vol. 21 Issue 16, p972 

    Patient and public involvement (PPI) has become increasingly important to ensure the needs of patients are fully considered when they participate in clinical trials. Most funders now require a plan for PPI in grant applications. When fully embraced and correctly implemented, PPI adds an...

  • NIH UNVEILS DATABASE ON CLINICAL TRIALS. Berry, James // Journal of the American Dental Association (JADA);May2000, Vol. 131 Issue 5, p572 

    Focuses on the United States National Institutes of Health's introduction of a database dealing with federal and private medical studies. Up-to-date information on promising patient-oriented research; Initial phases of the project; Major purpose of clinical trials.

  • One from the many: Honing multicenter clinical trials.  // Clinical Trials Administrator;Feb2009, Vol. 7 Issue 2, p19 

    The article reveals the importance of a departmental research infrastructure to make clinical trial (CT) research more efficient and feasible when multicenter clinical trials are involved. An example is the obstetrics and gynecology research network (OGRN) which has a multicenter clinical trial...

  • Amend protocols to participants' needs.  // IRB Advisor;Dec2008, Vol. 8 Issue 12, p142 

    The article discusses proposals to amend clinical trial criteria to meet the needs of study participants. According to Erin J. Iturriaga, a nurse consultant and project officer for the National Institutes of Health (NIH) in Bethesda, Maryland, some of the criteria can be used generally, but in...

  • The status of clinical trials: Cause for concern. Nussenblatt, Robert B.; Meinert, Curtis L. // Journal of Translational Medicine;2010, Vol. 8, p65 

    Background: Americans see clinical research as important, with over 15 million American residents participating in NIH-sponsored studies in 2008 and growing yearly. Methods: Documents reporting NIH supported Clinical Research projects were reviewed. Results: When compared with other studies, the...

  • NIH Awards Largest Trial Grant Ever; APTA Members to Lead Study.  // PT: Magazine of Physical Therapy;Jan2006, Vol. 14 Issue 1, p68 

    The article presents information on the largest rehabilitation trial ever funded by the National Institutes of Health (NIH). This clinical trial named "Locomotor Experience Applied Post-Stroke" has been designed to investigate the best timing and effectiveness of particular physical therapist...

  • PRODUCTS & SERVICES.  // Hem/Onc Today;2/10/2008, Vol. 9 Issue 2, p36 

    The article presents news briefs on clinical trials. The U.S. National Institutes of Health (NIH) currently hosts a phase-3 clinical trial to determine how effective oral suberoylanilide is in patients with advanced malignant pleural mesothelioma. Researchers are now enrolling patients in a...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics